4 Recruiting Pancreatic Adenocarcinoma Clinical Trials in California
Explore active pancreatic adenocarcinoma research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Pancreatic Adenocarcinoma Studies in California
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
📍 Stanford University, School of Medicine — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔